Renaissance Technologies - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$5,027,000
-86.2%
94,058
-69.7%
0.01%
-88.5%
Q3 2015$36,544,000
+1265.6%
310,458
+183.9%
0.09%
+1142.9%
Q3 2014$2,676,000
-27.3%
109,358
-47.3%
0.01%
-22.2%
Q2 2014$3,680,000
+462.7%
207,578
+534.8%
0.01%
+350.0%
Q1 2014$654,000
-63.2%
32,700
-69.1%
0.00%
-50.0%
Q4 2013$1,775,000105,8000.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$61,778,00025.76%
VHCP Management, LLC 1,178,474$68,175,00015.70%
Palo Alto Investors LP 3,259,045$188,536,0009.32%
HWG Holdings LP 69,898$4,044,0006.53%
Consonance Capital Management LP 830,151$48,024,0004.37%
EMORY UNIVERSITY 23,325$1,349,0002.55%
Baker Brothers Advisors 4,204,702$243,242,0002.02%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 117,875$6,819,0001.55%
KINGDON CAPITAL MANAGEMENT, L.L.C. 595,300$34,438,0001.46%
Century Capital Management, LLC 1,030,483$45,609,0001.31%
View complete list of ANACOR PHARMACEUTICALS INC shareholders